Lexicon Pharmaceuticals Inc (LXRX)
1.63
+0.01
(+0.62%)
USD |
NASDAQ |
Apr 18, 16:00
1.63
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Price: 1.63 for April 18, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 17, 2024 | 1.72 | 1.78 | 1.61 | 1.62 | 5.520M |
| Apr 16, 2024 | 1.83 | 1.84 | 1.69 | 1.695 | 4.592M |
| Apr 15, 2024 | 1.95 | 1.96 | 1.84 | 1.87 | 3.492M |
| Apr 12, 2024 | 2.01 | 2.039 | 1.93 | 1.97 | 1.870M |
| Apr 11, 2024 | 2.03 | 2.09 | 1.975 | 2.03 | 1.750M |
| Apr 10, 2024 | 2.04 | 2.04 | 1.97 | 2.02 | 2.599M |
| Apr 09, 2024 | 2.11 | 2.168 | 2.035 | 2.07 | 2.217M |
| Apr 08, 2024 | 2.07 | 2.11 | 2.03 | 2.09 | 1.333M |
| Apr 05, 2024 | 2.04 | 2.095 | 2.01 | 2.06 | 1.234M |
| Apr 04, 2024 | 2.08 | 2.19 | 2.03 | 2.06 | 2.014M |
| Apr 03, 2024 | 2.22 | 2.239 | 2.03 | 2.04 | 4.392M |
| Apr 02, 2024 | 2.27 | 2.28 | 2.18 | 2.21 | 2.046M |
| Apr 01, 2024 | 2.45 | 2.45 | 2.28 | 2.28 | 1.805M |
| Mar 28, 2024 | 2.18 | 2.47 | 2.13 | 2.40 | 7.061M |
| Mar 27, 2024 | 2.00 | 2.29 | 1.992 | 2.19 | 5.171M |
| Mar 26, 2024 | 2.10 | 2.17 | 1.96 | 1.98 | 4.400M |
| Mar 25, 2024 | 2.26 | 2.355 | 2.12 | 2.12 | 4.182M |
| Mar 22, 2024 | 2.43 | 2.448 | 2.255 | 2.26 | 3.255M |
| Mar 21, 2024 | 2.47 | 2.59 | 2.39 | 2.41 | 2.909M |
| Mar 20, 2024 | 2.43 | 2.52 | 2.37 | 2.49 | 1.643M |
| Mar 19, 2024 | 2.48 | 2.575 | 2.41 | 2.44 | 2.895M |
| Mar 18, 2024 | 2.57 | 2.59 | 2.50 | 2.52 | 2.429M |
| Mar 15, 2024 | 2.45 | 2.62 | 2.435 | 2.60 | 7.483M |
| Mar 14, 2024 | 2.46 | 2.515 | 2.39 | 2.43 | 3.084M |
| Mar 13, 2024 | 2.48 | 2.635 | 2.39 | 2.48 | 5.957M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.00
Minimum
Oct 09 2023
9.09
Maximum
Feb 02 2021
3.048
Average
2.42
Median
Sep 12 2019
Price Benchmarks
| Novavax Inc | 3.895 |
| AIM ImmunoTech Inc | 0.4755 |
| Perspective Therapeutics Inc | 1.455 |
| Protalix BioTherapeutics Inc | 1.125 |
| Armata Pharmaceuticals Inc | 2.595 |
Price Related Metrics
| PS Ratio | 298.91 |
| PEG Ratio | -0.0654 |
| Price to Book Value | 4.311 |
| Earnings Yield | -49.08% |
| Market Cap | 401.37M |
| PEGY Ratio | -0.0654 |